You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hyperparathyroidism

Showing 26 - 50 of 902
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Hyperparathyroidism Trial in Odense C (Contrast-enhanced ultrasound)

Completed
  • Primary Hyperparathyroidism
  • Contrast-enhanced ultrasound
  • Odense C, Denmark
    Odense University Hospital
Apr 7, 2022

Pituitary ACTH Hypersecretion, Acromegaly, Diabetes, Type 1 Trial in Moscow (Cholecalciferol 15000 UNT/ML Oral Solution)

Completed
  • Pituitary ACTH Hypersecretion
  • +3 more
  • Cholecalciferol 15000 UNT/ML Oral Solution
  • Moscow, Russian Federation
    Endocrinology Research Centre, Moscow
Aug 10, 2022

Primary Hyperparathyroidism and Gut Microbiota

Recruiting
  • Hyperparathyroidism, Primary
  • there will be no intervention, this is an observational study
  • Lausanne, Switzerland
    Patrizia D'amelio
Feb 28, 2022

Hyperparathyroidism, Hypercalcemia, Parathyroid Tumor Trial run by the NIDDK (68Ga-Dotatate, 18F-DOPA)

Completed
Has Results
  • Hyperparathyroidism
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
May 12, 2022

Parathyroid Diseases, Parathyroid Dysfunction, Parathyroid Tumors Trial in San Francisco (Parathyroid Eye (PTeye))

Active, not recruiting
  • Parathyroid Diseases
  • +9 more
  • Parathyroid Eye (PTeye)
  • San Francisco, California
    University of California, San Francisco
Jul 27, 2022

Secondary Hyperparathyroidism Trial in Baltimore (Teriparatide)

Completed
Has Results
  • Secondary Hyperparathyroidism
  • Baltimore, Maryland
    University of Maryland School of Medicine Division of Endocrinol
Mar 30, 2022

Secondary Hyperparathyroidism Trial (SHR6508;Placebo)

Not yet recruiting
  • Secondary Hyperparathyroidism
  • SHR6508；Placebo
  • (no location specified)
Jan 20, 2022

Parathyroid Adenoma, Parathyroid Tumors, Parathyroid Hyperplasia Trial in Nashville (NIRAF Detection Technology)

Active, not recruiting
  • Parathyroid Adenoma
  • +5 more
  • NIRAF Detection Technology
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Dec 19, 2022

Primary Hyperparathyroidism Trial in Lund (Parathyroid surgery)

Recruiting
  • Primary Hyperparathyroidism
  • Parathyroid surgery
  • Lund, Sweden
    Skåne University Hospital, Department of Surgery, Lund
Feb 28, 2022

Hyperparathyroidism, Secondary Trial in Sao Paulo (Subtotal Parathyroidectomy, Total Parathyroidectomy + 45 autografts, Total

Active, not recruiting
  • Hyperparathyroidism, Secondary
  • Subtotal Parathyroidectomy
  • +2 more
  • Sao Paulo, SP, Brazil
    University of Sao Paulo General Hospital
May 23, 2022

Chronic Kidney Disease 5D, Secondary Hyperparathyroidism Due to Renal Causes, Vitamin D Deficiency Trial (High-dose vitamin D2

Recruiting
  • Chronic Kidney Disease 5D
  • +2 more
  • High-dose vitamin D2 softgels
  • +2 more
  • Xi'an, Shaanxi, China
    The First Affiliated Hospital of Xi 'an Jiaotong University
Jan 5, 2023

Sodium Zirconium Cyclosilicate, Hyperkalemia, Hyperparathyroidism, Secondary Trial (Sodium zirconium cyclosilicate)

Completed
  • Sodium Zirconium Cyclosilicate
  • +2 more
  • Sodium zirconium cyclosilicate
  • (no location specified)
May 16, 2022

Secondary Hyperparathyroidism Trial in Worldwide (Etelcalcetide)

Recruiting
  • Secondary Hyperparathyroidism
  • Gent, Belgium
  • +19 more
Dec 8, 2022

Secondary Hyperparathyroidism Trial (Paricalcitol, Placebo)

Not yet recruiting
  • Secondary Hyperparathyroidism
  • (no location specified)
Jan 27, 2022

Parathyroidectomy on Cardiovascular Calcification in

Active, not recruiting
  • Secondary Hyperparathyroidism
  • +3 more
    • Saint Petersburg, Russian Federation
      Saint-Petersburg State University, Clinic of advanced medical te
    Nov 2, 2022

    Primary Hyperparathyroidism, Thyroid Disease, Parathyroid Diseases Trial in Ostrava (Conventional (dual-phase) SPECT/CT,

    Completed
    • Primary Hyperparathyroidism
    • +3 more
    • Conventional (dual-phase) SPECT/CT
    • +3 more
    • Ostrava, Moravian-Silesian Region, Czechia
      University Hospital Ostrava
    Dec 6, 2022

    Primary Hyperparathyroidism Trial in Boston (eplerenone, amiloride, Placebo)

    Completed
    • Primary Hyperparathyroidism
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Nov 26, 2021

    Hemodialysis, Chronic Pain, Hyperparathyroidism Trial in Taipei (Vitamin D, Placebo)

    Not yet recruiting
    • Hemodialysis
    • +2 more
    • Vitamin D
    • Placebo
    • Taipei, Taiwan
      Taipei Medical University Hospital
    Dec 26, 2022

    (NIS) on Effectiveness in ND-CKD SHPT Patients

    Not yet recruiting
    • Chronic Kidney Disease
      • (no location specified)
      Jul 12, 2022

      Parathyroid Adenoma, Hyperparathyroidism, F18-choline Trial in Brest, Caen, Rennes (MIBI scintigraphy, F18-choline PET)

      Active, not recruiting
      • Parathyroid Adenoma
      • +2 more
      • MIBI scintigraphy
      • F18-choline PET
      • Brest, France
      • +3 more
      May 6, 2022

      Postmenopausal Osteoporosis, Hypovitaminosis D, Hyperparathyroidism Trial in Mexico City (Risedronate, Vitamin D)

      Completed
      • Postmenopausal Osteoporosis
      • +2 more
      • Mexico City, Mexico
        Peri-postmenopause and bone metabolism clinic. Regional Hospital
      Apr 20, 2022

      Secondary Hyperparathyroidism;Parathyroidectomy Trial in Nanjing (Parathyroidectomy)

      Recruiting
      • Secondary Hyperparathyroidism;Parathyroidectomy
      • Parathyroidectomy
      • Nanjing, China
        NanjingMU
      Sep 23, 2021

      Alterations in Muscle's Functional Characteristics After

      Completed
      • Hyperparathyroidism, Primary
      • Parathyroidectomy
        • Thessaloniki, Greece
          AHEPA University General Hospital, Aristotle University of Thess
        Aug 25, 2021

        Hyperparathyroidism, Primary Trial in San Francisco (18F-Fluorocholine, Positron Emission Tomography (PET))

        Completed
        Has Results
        • Hyperparathyroidism, Primary
        • San Francisco, California
          University of California, San Francisco
        Sep 21, 2021

        Parathyroid Gland Adenoma, Primary Hyperparathyroidism Trial in Buffalo (Laboratory Biomarker Analysis, Parathyroidectomy)

        Completed
        • Parathyroid Gland Adenoma
        • Primary Hyperparathyroidism
        • Laboratory Biomarker Analysis
        • Parathyroidectomy
        • Buffalo, New York
          Roswell Park Cancer Institute
        Aug 9, 2021